English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

To the Editor: Vitiligo is an acquired chronic depigmentation disorder of the skin resulting from selective destruction of melanocytes.[1] Although it is not a life‐threatening disease, it may lead to disfigurement and is associated with many other autoimmune diseases. According to a recent international consensus conference, vitiligo can be classified into two major forms: nonsegmental vitiligo (NSV) and segmental vitiligo (SV, accounts for 5–16% of all vitiligo cases). NSV typically evolves over time, in both distribution and extension patterns, including acrofacial, generalized, mucosal, and facial vitiligo [Figure 1a and 1b]. SV is relatively rare and is characterized by unilateral or banded distribution along the ganglion segment. SV usually has an early onset and spreads rapidly in the affected dermatomal area, including single SV, double SV, and the multi‐SV [Figure 1c and 1d].[2]

Rs3213758 in the RPGRIP1L Gene Associated with Susceptibility to Segmental Vitiligo in a Chinese Han Population